SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-036187
Filing Date
2023-11-02
Accepted
2023-11-02 07:08:44
Documents
56
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fhtx-20230930.htm   iXBRL 10-Q 812867
2 EX-10.1 ex101-employmentagreementx.htm EX-10.1 65914
3 EX-31.1 fhtx-20230930xex311.htm EX-31.1 10252
4 EX-31.2 fhtx-20230930xex312.htm EX-31.2 10231
5 EX-32.1 fhtx-20230930xex321.htm EX-32.1 4301
6 EX-32.2 fhtx-20230930xex322.htm EX-32.2 4286
12 GRAPHIC image_0.jpg GRAPHIC 11200
  Complete submission text file 0001628280-23-036187.txt   4073973

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fhtx-20230930.xsd EX-101.SCH 30207
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fhtx-20230930_cal.xml EX-101.CAL 49909
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fhtx-20230930_def.xml EX-101.DEF 117765
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fhtx-20230930_lab.xml EX-101.LAB 372199
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fhtx-20230930_pre.xml EX-101.PRE 228753
50 EXTRACTED XBRL INSTANCE DOCUMENT fhtx-20230930_htm.xml XML 479546
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Filer) CIK: 0001822462 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39634 | Film No.: 231370037
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences